543500 EVOQ

Evoq Remedies Share Price

₹3.25 -0.17 (-4.97%)

04 Mar, 2025 02:51

SIP TrendupStart SIP in EVOQ

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month -54.03%
  • Over 3 Month -59.12%
  • Over 6 Month -64.01%
  • Over 1 Year -74.55%
SIP Lightning

Smart Investing Starts Here Start SIP with Evoq Remedies for Steady Growth!

Invest Now

Evoq Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Evoq Remedies Financials

Evoq Remedies Technicals

EMA & SMA

Current Price
₹3.25
-0.17 (-4.97%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹5.50
  • 50 Day
  • ₹6.55
  • 100 Day
  • ₹7.35
  • 200 Day
  • ₹8.53

Resistance and Support

3.3 Pivot Speed
  • R3 3.50
  • R2 3.45
  • R1 3.35
  • S1 3.20
  • S2 3.15
  • S3 3.05

What's your outlook on Evoq Remedies?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Evoq Remedies has an operating revenue of Rs. 44.14 Cr. on a trailing 12-month basis. An annual revenue de-growth of -76% needs improvement, Pre-tax margin of 15% is great, ROE of 1% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 30 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Evoq Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-05-27 Audited Results
2024-01-22 Preferential issue of shares
2023-11-10 Half Yearly Results (Revised)
2023-05-25 Audited Results
2022-11-07 Half Yearly Results & Rights issue

Evoq Remedies F&O

Evoq Remedies Shareholding Pattern

11.21%
85.75%
3.04%

About Evoq Remedies

  • NSE Symbol
  • EVOQ
  • BSE Symbol
  • 543500
  • Managing Director
  • Mr. Bhumishth Patel
  • ISIN
  • INE0JVD01011

Similar Stocks to Evoq Remedies

Evoq Remedies FAQs

Evoq Remedies share price is ₹3 As on 04 March, 2025 | 02:37

The Market Cap of Evoq Remedies is ₹8.1 Cr As on 04 March, 2025 | 02:37

The P/E ratio of Evoq Remedies is 17.9 As on 04 March, 2025 | 02:37

The PB ratio of Evoq Remedies is 0.2 As on 04 March, 2025 | 02:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23